🇨🇦 B55R1 and placebo for B55R2 in Canada

B55R1 and placebo for B55R2 (B55R1 and placebo for B55R2) regulatory status in Canada.

Marketing authorisation

B55R1 and placebo for B55R2 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Canada

Frequently asked questions

Is B55R1 and placebo for B55R2 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for B55R1 and placebo for B55R2 in Canada?

AJU Pharm Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.